About Engineered Molding Technology
Engineered Molding Technology is an Industrial Goods & Manufacturing company based in Clifton Park (United States) founded in 2010, and was acquired by Repligen in June 2020. Silicon molded products are manufactured for biopharmaceutical applications. Its focus areas include Healthcare and Medical Products Manufacturing Machinery.
Company details
Engineered Molding Technology was founded in 2010 and is based in Clifton Park, United States. Operations focus on the production of silicon molded products tailored to the biopharmaceutical sector. Precision molding techniques are employed to create components that meet regulatory standards for medical and pharmaceutical uses. Services include custom design and manufacturing processes, with an emphasis on quality control and material expertise for sector-specific needs.
- Headquarters Clifton Park, United States
- Stage Acquired
- SectorsIndustrial Goods & Manufacturing
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website engineeredmolding.com
- Acquired by Repligen (Jun 2020)
Investors in Engineered Molding Technology
Engineered Molding Technology has secured backing from 1 investor. Prominent investors backing the company include Repligen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Products and services for biologic drug manufacturing are supplied. | 1981 | repligen.com | Waltham, United States |
Investor details for Engineered Molding Technology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Engineered Molding Technology
2 dated milestones of Engineered Molding Technology across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Engineered Molding Technology is founded.
- Exit Acquired by Repligen.
Top companies in Medical Manufacturing Machinery
3 companies that operate in the same segment as Engineered Molding Technology (Medical Manufacturing Machinery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Customized HMI products including switches and joysticks are manufactured. | 1952 | Vista, California, United States | ||||
Health equipment is manufactured by IDEX in the United States. | 1988 | Northbrook, Illinois, United States | USD 3.46 B | 9,000 | ||
Injection moulding machines are manufactured by Engel for industrial applications. | 1945 | York, Pennsylvania, United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Engineered Molding Technology
Engineered Molding Technology was founded in 2010.
Engineered Molding Technology is headquartered in Clifton Park, United States. It is registered at Clifton Park, New York, United States.
Engineered Molding Technology was founded in 2010 and is based in Clifton Park, United States. Operations focus on the production of silicon molded products tailored to the biopharmaceutical sector. Precision molding techniques are employed to create components that meet regulatory standards for medical and pharmaceutical uses. Services include custom design and manufacturing processes, with an emphasis on quality control and material expertise for sector-specific needs.
Engineered Molding Technology has 1 investor. Key investors include Repligen.
Yes. Engineered Molding Technology was acquired by Repligen in June 2020.
